Transesophageal echocardiography in patients with atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 7 II, 2003, Pages 1597-1603

  Asher, Craig R ^a   Klein, Allan L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atrial fibrillation; Direct current cardioversion; Left atrial appendage; Transesophageal echocardiography

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANALYTIC METHOD; ANTICOAGULATION; CARDIOVERSION; CLINICAL TRIAL; CONFERENCE PAPER; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART SURGERY; HOSPITALIZATION; HUMAN; IMAGE ANALYSIS; MEDICAL DECISION MAKING; PULMONARY VEIN; RISK ASSESSMENT; SAFETY; SINUS RHYTHM; SURGICAL TECHNIQUE; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

EID: 0037932781     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.t01-1-00237.x     Document Type: Conference Paper

References (37)

1. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 2000; 102:2619-2628.
2. Lee R, Nitta T, Schuessler RB, et al. The closed heart MAZE: A non-bypass surgical technique. Ann Thorac Surg 1999; 67:1696-1702.
3. Albers GW, Dalen JE, Laupacis A, et al. Antithrombotic therapy in atrial fibrillation. Chest 2001; 119(Suppl. 1):194S-206S.
4. Manning WJ, Silverman DI, Gordon SP, et al. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993; 328:750-755.
5. Klein AL, Grimm RA, Murray RB, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001; 344:1411-1420.
6. SPAF Investigators. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med 1998; 128:639-647.
7. Aschenberg W, Schluter M, Kremer P, et al. Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol 1986; 7:163-166.
8. Manning WJ, Weintraub RM, Waksmonski CA, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med 1995; 123:817-822.
9. Fatkin D, Scalia G, Jacobs N, et al. Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus. Am J Cardiol 1996; 77:321-323.
10. Black IW, Hopkins AP, Lee LC, et al. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients. Am Heart J 1993; 126:375-381.
11. Fatkin D, Kuchar DL, Thorburn CW, et al. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994; 23:307-316.
12. Black IW, Fatkin D, Sagar KB, et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation 1994; 89:2509-2513.
13. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23:961-969.
14. Leung DY, Black IW, Cranney GB, et al. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 1994; 24:755-762.
15. Kamp O, Verhorst PM, Welling RC, et al. Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. Eur Heart J 1999; 20:979-985.
16. Goldman ME, Pearce LA, Hart RG, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr 1999; 12:1080-1087.
17. Antonielli E, Pizzuti A, Palinkas A, et al. Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 2002; 39:1443-1449.
18. Jaber WA, Prior DL. Thamilarasan M, et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study. Am Heart J 2000; 140:150-156.
19. Yu WC, Hsu TL, Tai CT, et al. Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2001; 12:887-892.
20. Robbins IM, Colvin EV, Doyle TP, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation 1998; 98:1769-1775.
21. Sohn RH, Schiller NB. Left upper pulmonary vein stenosis 2 months after radiofrequency catheter ablation of atrial fibrillation. Circulation 2000; 101:e154-e155.
22. Klein AL, Murray RD, Grimm RA. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation. J Am Coll Cardiol 2001; 37:691-704.
23. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53:273-279.
24. Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation. Am J Cardiol 1969; 23:208-216.
25. Goldman MJ. The management of chronic atrial fibrillation. Prog Cardiovasc Dis 1960; 2:465-479.
26. Manning WJ, Leeman DE, Gotch PJ, et al. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 1989; 13:617-623.
27. Wijffels M, Kirchhof C, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: A study of awake chronically instrumented goats. Circulation 1995; 92:1954-1968.
28. Greenstein RS, Merz J, Fay W, et al. Time required to achieve therapeutic anticoagulation with warfarin prior to cardioversion for atrial fibrillation. (abstract) J Am Coll Cardiol 2001; 37:104A.
29. Klein AL, Grimm RA, Black IW, et al. Cardioversion guided by transesophageal echocardiography: The ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography. Ann Intern Med 1997; 126:200-209.
30. Carlsson J, Tebbe U, Rox J, et al. Cardioversion of atrial fibrillation in the elderly. ALKK-Study Group. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausaerzte. Am J Cardiol 1996; 78:1380-1384.
31. Manning WJ, Silverman DI, Keighley CS, et al. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study. J Am Coll Cardiol 1995; 25:1354-1361.
32. Weigner MJ, Patel U, Thomas LR, et al. Transesophageal echocardiography facilitated cardioversion from atrial fibrillation: Short-term safety and implications regarding maintenance of sinus rhythm. (abstract) Circulation 1998; 98(Suppl. I):1500.
33. Klein AL, Murray RD, Grimm RA, et al. Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiography guided and conventional anticoagulation therapies. Am J Cardiol 2003 (in press).
34. Seidl K, Rameken M, Drogemuller A, et al. Embolic events in patients with atrial fibrillation and effective anticoagulation: Value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study. J Am Coll Cardiol 2002; 39:1436-1442.
35. Murray RD, Shah A, Jasper SE, et al. Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: The ACUTE II pilot study. Am Heart J 2000; 139:1-7.
36. Stellbrink C, Hanrath P, Nixdorff U, et al. Low molecular weight heparin for prevention of thromboembolic complications in cardioversion - rationale and design of the ACE study (Anticoagulation in Cardioversion using Enoxaparin). Z Kardiol 2002; 91:249-254.
37. Asher CR, Klein AL. The ACUTE trial. Transesophageal echocardiography to guide cardioversion in atrial fibrillation. Cleve Clin J Med 2002; 69:713-718.